Pfizer’s Global Medical Grants: 2020 Osteoarthritis and Osteoarthritis Pain – Virtual Learning

There remains unmet need in the management of osteoarthritis and chronic pain associated with osteoarthritis. Given the recent and anticipated cancellation of many medical conferences worldwide, healthcare providers will have difficulty staying current with the newest recommendations for management/guidelines of OA and the emerging data for research/therapies under development to treat OA and OA pain. Through this RFP, it is our intent to support virtual programs for HCPs on Osteoarthritis and Chronic Pain associated with OA patient-centered standard of care and management including pain and function, the biopsychosocial aspects of the disease, the complexities and challenges of care, and the future of OA/OA pain management. Programs targeted towards reviewing data from cancelled or virtual rheumatology, pain, primary car

Funding & duration

Up to US $250,000 (approx. AUD $387,000).

Submission requirements & due date

Further information

Need help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.